NGM BIOPHARMACEUTICALS INC Annual Return On Assets in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from 2019 to 2023.
  • Ngm Biopharmaceuticals Inc Return On Assets for the quarter ending December 31, 2023 was -67.8 %, a 39.6% decline year-over-year.
  • Ngm Biopharmaceuticals Inc annual Return On Assets for 2023 was -67.8 %, a 39.6% decline from 2022.
  • Ngm Biopharmaceuticals Inc annual Return On Assets for 2022 was -48.5 %, a 70.1% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Return On Assets for 2021 was -28.5 %, a 5.12% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -67.8 -19.2 -39.6% Jan 1, 2023 Dec 31, 2023
2022 -48.5 -20 -70.1% Jan 1, 2022 Dec 31, 2022
2021 -28.5 +1.54 +5.12% Jan 1, 2021 Dec 31, 2021
2020 -30.1 -17.8 -146% Jan 1, 2020 Dec 31, 2020
2019 -12.2 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.